Balance between SIRT1 and DBC1 expression is lost in breast cancer.
SIRT1 (silent mating-type information regulation 2 homologue 1)-mediated cellular resistance to various stresses is negatively regulated by deleted in breast cancer 1 (DBC1), which was originally reported to be deleted in breast cancer. However, the suggested functions of SIRT1 as a potential tumor promoter and of DBC1 as a potential tumor suppressor have been challenged by observations of their respective down- and up-regulation in various cancers. The aim of the present study was to simultaneously evaluate the expression levels of SIRT1 and DBC1 in the normal and tumor breast tissues from 28 breast cancer patients and to determine correlations with clinicopathological variables. SIRT1 and DBC1 expression was higher in tumor tissues than in matched normal tissues at the protein level, but not at the transcriptional level. Overexpression of SIRT1 and DBC1 in tumor tissue was correlated with favorable and unfavorable clinicopathological factors, suggesting their pleiotropic functions as a potential tumor promoter and tumor suppressor in tumorigenesis. Interestingly, although the overall expression of SIRT1 and DBC1 increased in tumor breast tissues, the correlation between SIRT1 and DBC1 expression was weaker in tumor tissue than in normal tissue. This suggests that the negative regulation of SIRT1 by DBC1 may retard tumorigenesis in breast tissue. Therefore, the correlation between SIRT1 and DBC1 is a potential prognostic indicator in breast cancer.
Sung
Ji-Youn
JY
Department of Pathology, Kyung Hee University Medical Center, Seoul, Korea.
Kim
Ranah
R
Kim
Ja-Eun
JE
Lee
Juhie
J
D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics*; D015153:Blotting, Western; D001940:Breast / Q000502:physiology; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics*; D017931:DNA Primers; D018076:DNA, Complementary / Q000235:genetics; D005260:Female; D005784:Gene Amplification; D017353:Gene Deletion; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D011379:Prognosis; D012016:Reference Values; D020133:Reverse Transcriptase Polymerase Chain Reaction; D056564:Sirtuin 1 / Q000235:genetics*; D014158:Transcription, Genetic
D048868:Adaptor Proteins, Signal Transducing; C527450:CCAR2 protein, human; D017931:DNA Primers; D018076:DNA, Complementary; C447939:SIRT1 protein, human; D056564:Sirtuin 1
Nephrol Dial Transplant. 2006 Feb;21(2):288-98
16249193
Clin Cancer Res. 2009 Jul 1;15(13):4453-9
19509139
Cell. 2001 Oct 19;107(2):149-59
11672523
Neoplasia. 2009 Aug;11(8):763-70
19649206
Am J Surg Pathol. 2008 Oct;32(10):1523-31
18724249
Pathology. 2009;41(4):366-71
19404850
Cancer Res. 2007 Jul 15;67(14):6612-8
17638871
Cell Cycle. 2009 Nov 15;8(22):3784-5
19855164
Mol Cell. 2008 Oct 10;32(1):11-20
18851829
Arch Dermatol Res. 2007 May;299(2):103-6
17180656
Genes Cells. 2005 Apr;10(4):321-32
15773895
Oncogene. 2009 Jan 22;28(3):445-60
18850005
J Cell Physiol. 2007 Jan;210(1):161-6
16998810
Mod Pathol. 1998 Feb;11(2):155-68
9504686
Nature. 2008 Jan 31;451(7178):583-6
18235501
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13647-52
12370419
J Biol Chem. 2009 Mar 13;284(11):6832-40
19126541
Anticancer Res. 1998 Jan-Feb;18(1B):571-6
9568179
Cell. 2008 Nov 28;135(5):907-18
19041753
PLoS One. 2008 Apr 16;3(4):e2020
18414679
Cancer Cell. 2008 Oct 7;14(4):312-23
18835033
Mol Endocrinol. 2007 Jul;21(7):1526-36
17473282
EMBO J. 2004 Jun 16;23(12):2369-80
15152190
Cancer Res. 2005 Nov 15;65(22):10183-7
16288004
Mol Cell. 2007 Oct 26;28(2):277-90
17964266
Annu Rev Biochem. 2004;73:417-35
15189148
Nature. 2008 Jan 31;451(7178):587-90
18235502
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11005-10
16043716
Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1859-64
15684044
PLoS Genet. 2006 Mar;2(3):e40
16596166
J Biol Chem. 2009 Jul 3;284(27):18210-7
19433578
Cancer Res Treat. 2006 Dec;38(4):218-23
19771246
Biotechnol J. 2007 Nov;2(11):1360-8
17806102
Trends Biochem Sci. 2008 Nov;33(11):517-25
18805010
Cell Cycle. 2009 Sep 15;8(18):2932-5
19657230
J Clin Oncol. 1999 Jul;17(7):1983-7
10561248
Mol Cancer. 2006 Dec 02;5:67
17140455
Cell. 2004 Feb 20;116(4):551-63
14980222
Biochem J. 2007 Nov 1;407(3):451-60
17620057
Biochem J. 2007 May 15;404(1):1-13
17447894
JAMA. 2006 Jun 7;295(21):2492-502
16757721
Leukemia. 2005 Oct;19(10):1751-9
16121216
Biochem Biophys Res Commun. 2008 Aug 29;373(3):423-8
18573234